Literature DB >> 21354450

Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.

Marie Angèle Robic1, Bogdan Procopet, Sophie Métivier, Jean Marie Péron, Janick Selves, Jean Pierre Vinel, Christophe Bureau.   

Abstract

BACKGROUND & AIMS: The prognosis of patients with chronic liver disease is to a great extent determined by the presence and degree of portal hypertension (PHT). Hepatic venous pressure gradient (HVPG) has been shown to be an accurate prognostic index in patients with cirrhosis. Transient elastography is a non-invasive procedure that assesses liver fibrosis through the measurement of liver stiffness (LS). In several reports, LS was found to be correlated with HVPG. LS could therefore be useful to identify patients with significant PHT. The aim of the present study was to prospectively assess and to compare the prognostic performances of LS and HVPG in patients with chronic liver disease.
METHODS: One hundred patients with chronic liver disease underwent LS and HVPG measurements on the same day. Patients were thereafter followed-up for 2 years or until they experienced a complication related to their liver disease.
RESULTS: Within the two-year follow-up, 41 patients developed, at least, one liver disease related complication. The performances of HVPG and LS for predicting the occurrence of these complications were not significantly different: AUROC 0.815 [0.727-0.903] and 0.837 [0.754-0.920], respectively. When considering only complications related to PHT, both methods were found to be similarly accurate: AUROC 0.830 [0.751-0.910] and 0.845 [0.767-0.823], for HVPG and LS, respectively. When patients were divided in two groups according to a LS value below or above 21.1kPa, actuarial rates of remaining free of any complication at 2 years were 85.4% vs. 29.5%, respectively. When only PHT related complications were considered, these rates were 100% vs. 47.5%, respectively. The performances of LS and HVPG were also similar in the subgroup of 65 patients with cirrhosis.
CONCLUSIONS: LS proved as effective as HVPG in predicting clinical decompensation and PHT related complications in patients with chronic liver disease. Therefore, LS could be a valuable clinical tool to avoid invasive procedures.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21354450     DOI: 10.1016/j.jhep.2011.01.051

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  81 in total

Review 1.  Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan(®)).

Authors:  Monica Lupsor-Platon; Radu Badea
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 2.  Management of hepatocellular carcinoma.

Authors:  P Fitzmorris; M Shoreibah; B S Anand; A K Singal
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-27       Impact factor: 4.553

3.  Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.

Authors:  Ken Liu; Vincent Wai-Sun Wong; Keith Lau; Sienna Du Liu; Yee-Kit Tse; Terry Cheuk-Fung Yip; Raymond Kwok; Alex Yiu-Wa Chan; Henry Lik-Yuen Chan; Grace Lai-Hung Wong
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

Review 4.  Critical comparison of elastography methods to assess chronic liver disease.

Authors:  Mireen Friedrich-Rust; Thierry Poynard; Laurent Castera
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

Review 5.  Invasive and non-invasive diagnosis of cirrhosis and portal hypertension.

Authors:  Moon Young Kim; Woo Kyoung Jeong; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

6.  Clinical role of non-invasive assessment of portal hypertension.

Authors:  Massimo Bolognesi; Marco Di Pascoli; David Sacerdoti
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

7.  Strain elastography for assessment of liver fibrosis and prognosis in patients with chronic liver diseases.

Authors:  Kazuto Tajiri; Kengo Kawai; Toshiro Sugiyama
Journal:  J Gastroenterol       Date:  2016-10-27       Impact factor: 7.527

8.  Assessment of liver stiffness measurement: novel intraoperative blood loss predictor?

Authors:  Min-Soo Kim; Jeong-Rim Lee
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

Review 9.  Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond.

Authors:  Horia Stefanescu; Bogdan Procopet
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 10.  Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension.

Authors:  Virginia Hernandez-Gea; Fanny Turon; Annalisa Berzigotti; Augusto Villanueva
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.